- Home
- FOSL vs COYA Comparison
FOSL vs COYA Comparison
Compare FOSL & COYA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FOSL
- COYA
- Stock Information
- Founded
- FOSL 1984
- COYA 2020
- Country
- FOSL United States
- COYA United States
- Employees
- FOSL N/A
- COYA N/A
- Industry
- FOSL Consumer Specialties
- COYA Biotechnology: Pharmaceutical Preparations
- Sector
- FOSL Consumer Discretionary
- COYA Health Care
- Exchange
- FOSL Nasdaq
- COYA Nasdaq
- Market Cap
- FOSL 100.0M
- COYA 99.8M
- IPO Year
- FOSL 1993
- COYA 2022
- Fundamental
- Price
- FOSL $1.31
- COYA $5.51
- Analyst Decision
- FOSL
- COYA Strong Buy
- Analyst Count
- FOSL 0
- COYA 4
- Target Price
- FOSL N/A
- COYA $17.00
- AVG Volume (30 Days)
- FOSL 170.1K
- COYA 41.5K
- Earning Date
- FOSL 08-07-2025
- COYA 08-11-2025
- Dividend Yield
- FOSL N/A
- COYA N/A
- EPS Growth
- FOSL N/A
- COYA N/A
- EPS
- FOSL N/A
- COYA N/A
- Revenue
- FOSL $1,123,399,000.00
- COYA $3,685,107.00
- Revenue This Year
- FOSL N/A
- COYA $105.26
- Revenue Next Year
- FOSL N/A
- COYA N/A
- P/E Ratio
- FOSL N/A
- COYA N/A
- Revenue Growth
- FOSL N/A
- COYA N/A
- 52 Week Low
- FOSL $0.86
- COYA $4.65
- 52 Week High
- FOSL $2.61
- COYA $10.24
- Technical
- Relative Strength Index (RSI)
- FOSL 50.31
- COYA 45.71
- Support Level
- FOSL $1.30
- COYA $5.30
- Resistance Level
- FOSL $1.41
- COYA $5.87
- Average True Range (ATR)
- FOSL 0.08
- COYA 0.38
- MACD
- FOSL -0.02
- COYA -0.01
- Stochastic Oscillator
- FOSL 30.00
- COYA 33.96
About FOSL Fossil Group Inc.
Fossil Group Inc is a design, innovation and distribution company in consumer fashion accessories. The products include traditional watches, smartwatches, jewelry, handbags, small leather goods, belts and sunglasses. The reportable segments are comprised of 1) Americas segment includes sales in Canada, Latin America and the United States. 2) Europe segment includes sales in European countries, the Middle East and Africa. 3) Asia segment includes sales in Australia, China, India, Indonesia, Japan, Malaysia, New Zealand, Singapore, South Korea and Thailand. Each reportable operating segment includes sales to wholesale and distributor customers, and sales through Company-owned retail stores and e-commerce activities based on the location of the selling entity.
About COYA Coya Therapeutics Inc.
Coya Therapeutics Inc is a clinical-stage biotechnology company focused on developing proprietary medicinal products to modulate the function of regulatory T cells. It is developing its multi-modality Treg therapies for neurodegenerative, autoimmune, and metabolic diseases.